Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Ovarian Neoplasms

  Free Subscription


17.02.2020

3 BMC Cancer
2 Cancer Res
1 Eur J Obstet Gynecol Reprod Biol
3 Gynecol Oncol
1 Int J Cancer
2 Int J Gynaecol Obstet


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. WANG Y, Ren F, Song Z, Chen P, et al
    Statin use and the risk of ovarian and endometrial cancers: a meta-analysis.
    BMC Cancer. 2019;19:730.
    PubMed     Text format     Abstract available

  2. ENGQVIST H, Parris TZ, Kovacs A, Nemes S, et al
    Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas.
    BMC Cancer. 2019;19:928.
    PubMed     Text format     Abstract available

  3. HE Y, Li T, Liu J, Ou Q, et al
    Early onset neutropenia: a useful predictor of chemosensitivity and favorable prognosis in patients with serous ovarian cancer.
    BMC Cancer. 2020;20:116.
    PubMed     Text format     Abstract available


    Cancer Res

  4. MUKHERJEE A, Chiang CY, Daifotis HA, Nieman KM, et al
    Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance.
    Cancer Res. 2020 Feb 13. pii: 0008-5472.CAN-19-1999.
    PubMed     Text format     Abstract available

  5. PRICE C, Gill S, Ho ZV, Davidson SM, et al
    Genome-wide interrogation of human cancers identifies EGLN1 dependency in clear cell ovarian cancers.
    Cancer Res. 2019 Mar 21. pii: 0008-5472.CAN-18-2674.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  6. MEYDANLI MM, Aslan K, Oz M, Muftuoglu KH, et al
    A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
    Eur J Obstet Gynecol Reprod Biol. 2019;240:310-315.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  7. PETERSEN S, Wilson AJ, Hirst J, Roby KF, et al
    CCNE1 and BRD4 co-amplification in high-grade serous ovarian cancer is associated with poor clinical outcomes.
    Gynecol Oncol. 2020 Feb 7. pii: S0090-8258(20)30091.
    PubMed     Text format     Abstract available

  8. PIAO J, Lee EJ, Lee M
    Association between pelvic inflammatory disease and risk of ovarian cancer: An updated meta-analysis.
    Gynecol Oncol. 2020 Feb 6. pii: S0090-8258(20)30097.
    PubMed     Text format     Abstract available

  9. FREY MK, Lee SS, Gerber D, Schwartz ZP, et al
    Facilitated referral pathway for genetic testing at the time of ovarian cancer diagnosis: uptake of genetic counseling and testing and impact on patient-reported stress, anxiety and depression.
    Gynecol Oncol. 2020 Feb 11. pii: S0090-8258(20)30007.
    PubMed     Text format     Abstract available


    Int J Cancer

  10. KOTSOPOULOS J, Narod SA
    Prophylactic salpingectomy for the prevention of ovarian cancer; who should we target?
    Int J Cancer. 2020 Feb 9. doi: 10.1002/ijc.32916.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  11. VERMA S, Bakshi D, Sharma V, Sharma I, et al
    Genetic variants of DNAH11 and LRFN2 genes and their association with ovarian and breast cancer.
    Int J Gynaecol Obstet. 2019 Oct 12. doi: 10.1002/ijgo.12997.
    PubMed     Text format     Abstract available

  12. SALMAN L, Sabah G, Jakobson-Setton A, Raban O, et al
    Neutrophil-to-lymphocyte ratio as a prognostic factor in advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy.
    Int J Gynaecol Obstet. 2019 Sep 30. doi: 10.1002/ijgo.12986.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: